Literature DB >> 3880171

Periodic movements in sleep and sleep-wake complaint.

P Saskin1, H Moldofsky, F A Lue.   

Abstract

Periodic movements during sleep (PMS) are frequent, involuntary movements, usually of the lower extremities, that disrupt sleep. Twelve patients (nine men and three women, mean age 53.9 years) with a complaint of persistent insomnia (DIMS) were compared with 11 patients (eight men and three women, mean age 53.0 years) complaining of excessive daytime sleepiness (DOES). DIMS patients had more PMS (both absolute and relative), a longer delay to sleep onset and to REM onset, more wakefulness after sleep onset, and less total sleep time. Although the fragmentation of physiological sleep was more severe in the DIMS patients, those individuals with DOES reported cognitive intrusions during their sleep. While DOES patients may be regarded as "sleeping through" the brief arousals associated with leg activity during sleep, there appears to be sufficient cognitive awareness of the nocturnal interruption to precipitate a complaint of daytime sleepiness. Insomnia patients, however, appear to experience longer and more frequent awakenings, which are proportional to increased fragmentation of sleep.

Entities:  

Mesh:

Year:  1985        PMID: 3880171     DOI: 10.1093/sleep/8.4.319

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  3 in total

1.  Prevalence and correlates of alpha-delta sleep in major depressive disorders.

Authors:  Nattapong Jaimchariyatam; Carlos L Rodriguez; Kumar Budur
Journal:  Innov Clin Neurosci       Date:  2011-07

2.  Double-blind evaluation of clonazepam on periodic leg movements in sleep.

Authors:  R Peled; P Lavie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

3.  Experienced mindfulness meditators exhibit higher parietal-occipital EEG gamma activity during NREM sleep.

Authors:  Fabio Ferrarelli; Richard Smith; Daniela Dentico; Brady A Riedner; Corinna Zennig; Ruth M Benca; Antoine Lutz; Richard J Davidson; Giulio Tononi
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.